Autologous valve replacement - CD133+ stem cell-plus-fibrin composite-based sprayed cell seeding for intraoperative heart valve tissue engineering

Tissue Engineering - Part C: Methods

Volumn 17, Issue 3, 2011, Pages 299-309

  Kaminski, Alexander ^a   Klopsch, Christian ^a   Mark, Peter ^a   Yerebakan, Can ^a   Donndorf, Peter ^a   Gäbel, Ralf ^a   Eisert, Friederike ^a   Hasken, Stefan ^b   Kreitz, Sebastian ^b   Glass, Aenne ^a   Jockenhövel, Stefan ^b   Ma, Nan ^a   Kundt, Guenther ^a   Liebold, Andreas ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELL PROLIFERATION; ENDOTHELIAL CELLS; GRAFTS; OPTIMIZATION; SELF ASSEMBLY; STEM CELLS; SURFACE TESTING; TESTING; TISSUE ENGINEERING;

AUTOLOGOUS GRAFTS; BONE MARROW; CELL SEEDING; DECELLULARIZED; DELIVERY SYSTEMS; DYNAMIC TESTING; ENGRAFTMENT; FLOW CONDITION; HEART VALVES; HUMAN BONE MARROW; IN-VIVO; INTRA-OPERATIVE; MATRIX; MICROSCOPIC ANALYSIS; PERIPHERAL BLOOD; ULTRASONIC ANALYSIS; VALVE REPLACEMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR;

HEART VALVE PROSTHESES;

SUS;

CD133 ANTIGEN; FIBRIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; TISSUE SCAFFOLD;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; ENDOTHELIUM CELL; HEART VALVE PROSTHESIS; HUMAN; MATERIALS TESTING; METABOLISM; METHODOLOGY; PEROPERATIVE CARE; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANTIGENS, CD; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBRIN; GLYCOPROTEINS; HEART VALVE PROSTHESIS; HUMANS; INTRAOPERATIVE CARE; MATERIALS TESTING; PEPTIDES; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79952136489     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2010.0051     Document Type: Article

References (41)

1. Rabago, G. A worldwide overview of valve usage. In: Rabago, G., ed. Heart Valve Replacement & Future Trends in Cardiac Surgery. New York: Futura Publishing Company, 1987.
2. Jamieson, W. R. Modern cardiac valve devices-bioprostheses and mechanical prostheses: state of the art. J Cardiac Surg 8, 89, 1993.
3. Hammermeister, K. E., Sethi, G. K., Henderson, W. G., Oprian, C., Kim, T., and Rahimtoola, S. A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis. N Engl J Med 18, 1289, 1993.
4. Cannegieter, S. C., Rosendaal, F. R., and Briet, E. Thromboembolic and bleeding complications in patients with mechanical heart valve prosthesis. Circulation 89, 635, 1994.
5. Rajani, B., Mee, R. B., and Ratliff, N. B. Evidence for rejection of homograft cardiac heart valves in infants. J Thorac Cardiovasc Surg 115, 111, 1998.
6. Mayer, J. E., Jr. In search of the ideal valve replacement device. J Thorac Cardiovasc Surg 122, 8, 2001.
7. Brown, J. W., Ruzmetov, M., Rodefeld, M. D., Vijay, P., and Turrentine, M. W. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 80, 655, 2005.
8. Flanagan, T. C., Sachweh, J. S., Frese, J., Schnoring, H., Gronloh, N., Koch, S., Tolba, R. H., Schmitz-Rode, T., and Jockenhoevel, S. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng 15, 2965, 2009.
9. Sodian, R., Hoerstrup, S. P., Sperling, J. S., Daebritz, S., Martin, D. P., Moran, A. M., Kim, B. S., Schoen, F. J., Vacanti, J. P., and Mayer, J. E., Jr. Early in vivo experience with tissueengineered trileaflet heart valves. Circulation 102, 22, 2000.
10. Nehls, V., Schuchardt, E., and Drenckhahn, D. The effect of fibroblasts, vascular smooth muscle cells, and pericytes on sprout formation of endothelial cells in a fibrin gel angiogenesis system. Microvasc Res 48, 349, 1994.
11. Flanagan, T. C., Cornelissen, C., Koch, S., Tschoeke, B., Sachweh, J. S., Schmitz-Rode, T., and Jockenhoevel, S. The in-vitro development of autologous fibrin-based tissueengineered heart valves through optimised dynamic conditioning. Biomaterials 28, 3388, 2007.
12. Syedain, Z. H., Weinberg, J. S., and Tranquillo, R. T. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci U S A 105, 6537, 2008.
13. Rüger, B. M., Breuss, J., Hollemann, D., Yanagida, G., Fischer, M. B., Mosberger, I., Chott, A., Lang, I., Davis, P. F., Höcker, P., and Dettke, M. Vascular morphogenesis by adult bone marrow progenitor cells in three-dimensional fibrin matrices. Differentiation 76, 772, 2008.
14. Ma, N., Ladilov, Y., Moebius, J. M., Ong, L., Piechaczek, C., Dávid, A., Kaminski, A., Choi, Y. H., Li, W., Egger, D., Stamm, C., and Steinhoff, G. Intramyocardial delivery of human CD133+ cells in a SCID mouse cryoinjury model: bone marrow vs. cord blood-derived cells. Cardiovasc Res 71, 158, 2006.
15. Griese, D. P., Ehsan, A., Melo, L. G., Kong, D., Zhang, L., Mann, M. J., Pratt, R. E., Mulligan, R. C., and Dzau, V. J. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108, 2710, 2003.
16. Langer, R., and Vacanti, J. P. Tissue engineering. Science 260, 920, 1993.
17. Pörtner, R., Nagel-Heyer, S., Goepfert, C., Adamietz, P., and Meenen, N. M. Bioreactor design for tissue engineering. J Biosci Bioeng 100, 235, 2005.
18. Masuda, H., Kalka, C., Takahashi, T., Yoshida, M., Wada, M., Kobori, M., Itoh, R., Iwaguro, H., Eguchi, M., Iwami, Y., Tanaka, R., Nakagawa, Y., Sugimoto, A., Ninomiya, S., Hayashi, S., Kato, S., and Asahara, T. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101, 598, 2007.
19. Flanagan, T. C., Cornelissen, C., Koch, S., Tschoeke, B., Sachweh, J. S., Schmitz-Rode, T., and Jockenhoevel, S. The in-vitro development of autologous fibrin-based tissueengineered heart valves through optimised dynamic conditioning. Biomaterials 28, 3388, 2007.
20. Last'ovicka, J., Budinský, V., Spísek, R., and Bartůnková, J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cell Immunol 256, 79, 2009.
21. Huch, K., Stöve, J., Puhl, W., and Günther, K. P. Review and comparison of culture-techniques for articular chondrocytes. Z Orthop Ihre Grenzgeb 140, 145, 2002.
22. Al-Lamki, R. S., Bradley, J. R., and Pober, J. S. Endothelial cells in allograft rejection. Transplantation 86, 1340, 2008.
23. Urbich, C., and Dimmeler, S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 67, 1672, 2005.
24. Jockenhoevel, S., Zund, G., Hoerstrup, S. P., Chalabi, K., Sachweh, J. S., Demircan, L., Messmer, B. J., and Turina, M. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19, 424, 2001.
25. Grant, I., Warwick, K., Marshall, J., Green, C., and Martin, R. The co-application of sprayed cultured autologous keratinocytes and autologous fibrin sealant in a porcine wound model. Br J Plast Surg 55, 219, 2002.
26. Engelse, M. A., Laurens, N., Verloop, R. E., Koolwijk, P., and van Hinsbergh, V. W. Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation. Angiogenesis 11, 153, 2008.
27. Nehls, V., Schuchardt, E., and Drenckhahn, D. The effect of fibroblasts, vascular smooth muscle cells, and pericytes on sprout formation of endothelial cells in a fibrin gel angiogenesis system. Microvasc Res 48, 349, 1994.
28. van Hinsbergh, V. W., Collen, A., and Koolwijk, P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci 936, 426, 2001.
29. Urbich, C., and Dimmeler, S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95, 343, 2004.
30. Mizrak, D., Brittan, M., and Alison, M. R. CD133: molecule of the moment. J Pathol 214, 3, 2008.
31. Leone, A. M., Valgimigli, M., Giannico, M. B., Zaccone, V., Perfetti, M., D'Amario, D., Rebuzzi, A. G., and Crea, F. From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J 30, 890, 2009.
32. Klopsch, C., Furlani, D., Gäbel, R., Li, W., Pittermann, E., Ugurlucan, M., Kundt, G., Zingler, C., Titze, U., Wang, W., Ong, L. L., Wagner, K., Li, R. K., Ma, N., and Steinhoff, G. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J Cell Mol Med 13, 664, 2009.
33. Yamamoto, K., Takahashi, T., Asahara, T., Ohura, N., Sokabe, T., Kamiya, A., and Ando, J. Proliferation, differentiation, and tube formation by endothelial progenitor cells in response to shear stress. J Appl Physiol 95, 2081, 2003.
34. Buchta, C., Hedrich, H. C., Macher, M., Höcker, P., and Redl, H. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 26, 6233, 2005.
35. Horvath, K. A., and Berry, G. J.; ICEM Investigators. The incidence of emboli during cardiac surgery: a histopathologic analysis of 2297 patients. Heart Surg Forum 8, 61, 2005.
36. Furst, W., Banerjee, A., and Redl, H. Comparison of structure, strength and cytocompatibility of a fibrin matrix supplemented either with tranexamic acid or aprotinin. J Biomed Mater Res B Appl Biomater 82, 109, 2007.
37. Cholewinski, E., Dietrich, M., Flanagan, T. C., Schmitz-Rode, T., and Jockenhoevel, S. Tranexamic acid-an alternative to aprotinin in fibrin-based cardiovascular tissue engineering. Tissue Eng Part A 15, 3645, 2009.
38. Fiechtner, B. K., Nuttall, G. A., Johnson, M. E., Dong, Y., Sujirattanawimol, N., Oliver, W. C., Jr., Sarpal, R. S., Oyen, L. J., and Ereth, M. H. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg 92, 1131, 2001.
39. Schlag, M. G., Hopf, R., and Redl, H. Hind limb hyperexcitability following the application of fibrin sealants containing tranexamic acid to the lumbar spinal cord in rats. Eur J Trauma 68, 1125, 2004.
40. Koolwijk, P., van Erck, M. G., de Vree, W. J., Vermeer, M. A., Weich, H. A., Hanemaaijer, R., and van Hinsbergh, V. W. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132, 1177, 1996.
41. Paul, D., Samuel, S. M., and Maulik, N. Mesenchymal stem cell: present challenges and prospective cellular cardiomyoplasty approaches for myocardial regeneration. Antioxid Redox Signal 11, 1841, 2009.